Liposomal drug delivery systems (DDS) use lipid‑based vesicles to encapsulate therapeutics, improving targeting, stability, and safety while reducing systemic toxicity. The technology is especially valuable for oncology, infectious diseases, and emerging gene and RNA therapies.
The market was estimated at around USD 1.76 billion in 2023, about USD 1.95 billion in 2024, and is projected to...
Bangla